Viva Biotech Unveils AI-Driven Drug Discovery Platform
Viva Biotech has launched its AI-Driven Drug Discovery platform, featuring modules V-Scepter, V-Orb, and V-Mantle, to accelerate drug R&D processes.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Viva Biotech has launched its AI-Driven Drug Discovery platform, featuring modules V-Scepter, V-Orb, and V-Mantle, to accelerate drug R&D processes.
Subtle Medical's SubtleHD has received Health Canada approval, enabling faster MRI scans and improved image quality across Canada.
Invene has acquired Guidea to expand its capabilities in AI-driven healthcare solutions, announced in a press release.
MindHYVE.ai has announced a $22 million investment in Pakistan to establish it as a global hub for applied AI innovation, as stated in a press release. The initiative includes launching AI labs and deploying AI in education and healthcare.
OpenAI has launched HealthBench, an open-source dataset designed to benchmark AI models in healthcare, featuring contributions from 262 physicians across 60 countries.
Philips has announced a collaboration with NVIDIA to develop an AI-powered foundational model for MRI, aimed at enhancing image quality and diagnostic workflows.
iotaMotion has announced the first international use of its robotic-assisted cochlear implant technology at the University Hospital of Zurich, as part of a clinical investigation.
Trella Health has appointed David Kerr as Chief Technology Officer to lead its technology strategy and innovation efforts, announced in a press release.
Circulogene has announced the commercial launch of LungLifeAI, an AI-driven blood test for assessing indeterminate pulmonary nodules, as stated in a press release.
CareBand has been awarded a U.S. patent for its edge-computing wearable platform, which processes health and safety data locally over low-power networks, according to a press release.
Azenta Life Sciences and Form Bio have announced a strategic partnership to advance AAV gene therapy development through integrated sequencing and AI analysis.
Segmed has appointed David Gascoigne as its new CEO, transitioning co-founder Dr. Martin Willemink to Chief Scientific Officer and adding Dr. Yin Ho to its Board of Directors.
PharmaSentinel Limited has announced a license agreement with Pay10 for its AI-driven platform Medsii.com, enhancing healthcare analytics capabilities.
Ted Myles has been appointed as the new Chief Executive Officer of Cellarity, a life sciences company, and will also serve as CEO-Partner at Flagship Pioneering, according to a press release.
Avant Technologies and Ainnova Tech have begun acquisition discussions to strengthen their position in AI-driven healthcare, ahead of an FDA pre-submission meeting.
Apexon has announced a strategic partnership with Dataiku to enhance AI adoption in regulated sectors such as banking and healthcare.
PackGene Biotech, Inc. will present its latest advancements in scalable AAV manufacturing and AI-driven capsid engineering at the ASGCT 2025 meeting in New Orleans, according to a press release.
VUNO's AI-powered cardiac arrest risk management system, DeepCARS, has received CE MDR and UKCA certifications, accelerating its market expansion in Europe and the Middle East.
Amplifier Health has partnered with Xeomics to access voice data from over 750,000 patients, advancing their acoustic AI technology for healthcare diagnostics.
Eli Lilly and Company plans to invest up to $250 million in its collaboration with Purdue University to accelerate pharmaceutical innovation over the next eight years.